Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients

Metabolism: Clinical and Experimental

Volumn 46, Issue 3, 1997, Pages 287-291

  Kohno, Masakazu ^a   Murakawa, Koh Ichi ^a   Yasunari, Kenichi ^a   Yokokawa, Koji ^a   Horio, Takeshi ^a   Kano, Hiroaki ^a   Minami, Mieko ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE DEFORMABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LONG TERM CARE; MALE; PRIORITY JOURNAL; SHEAR STRESS; TREATMENT OUTCOME;

EID: 0031030075     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90255-9     Document Type: Article

References (33)

1. Brown BC, Zhao XQ, Sacco DE, et al: Lipid-lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87:1781-1791, 1993
2. Brown BC, Alberts JJ, Fisher L, et al: Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 339:1289-1298, 1990
3. Watts GF, Lewis B, Brunt JNH, et al: Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339:563-569, 1992
4. Ornish D, Brown SE, Scherwitz LW, et al: Can life style changes reverse coronary heart disease? Lancet 336:129-133, 1990
5. Ross R: The pathogenesis of atherosclerosis. N Engl J Med 314:488-500, 1986
6. Lücher TF, Richard V, Tschudi M, et al: Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 15:512-527, 1990
7. Zeiher AM, Drexler H, Saurbier B, et al: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension: Endotheliummediated coronary blood flow modulation in humans. J Clin Invest 92:652-662, 1993
8. Egashira K, Inou T, Yamada A, et al: Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 91:29-37, 1993
9. Sellke FW, Armstrong MI, Harrison DG: Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 81:1586-1593, 1990
10. Egashira K, Hirooka Y, Kai H, et al: Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89:2519-2524, 1994
11. Lowe G, McArdle B, Stromberg P, et al: Increased blood viscosity and fibrinolytic activity in type II hyperlipoproteinemia. Lancet 1:472-475, 1982
12. Aviram M, Brook G: Platelet activation by plasma lipoproteins. Prog Cardiovasc Dis 30:61-72, 1987
13. Weed RI: The importance of erythrocyte deformability. Am J Med 49:147-150, 1970
14. Chein S: Role of blood cells in microcirculatory regulation. Microvasc Res 29:129-151, 1985
15. Mohandas N, Phillips WM, Bessis M: Red blood cell deformability and hemolytic anemias. Semin Hematol 16:95-114, 1979
16. Bessis M, Mohandas N: A diffractometric method for the measurement of cellular deformability. Blood Cells 1:307-313, 1975
17. Bessis M, Mohandas N: Deformability of normal, shape-altered and pathological red cells. Blood Cells 1:315-321, 1975
18. Groner W, Mohandas N, Bessis M: New optical technique for measuring erythrocyte deformability with the ektacytometer. Clin Chem 26:1435-1442, 1980
19. Rasia RJ, Porta PE, Rosasco MG: Shear deformation measurement of suspended particles: Application to erythrocytes. Rev Sci Instrum 57:33-35, 1986
20. Murakawa K, Kohno M, Kinoshita Y, et al: Application of diffractometry and a linear image sensor to measurement of erythrocyte deformability. Biorheology 29:323-335, 1993
21. Murakawa K, Kohno M, Yasunari K, et al: Effect of salt-loading on erythrocyte deformability in spontaneously hypertensive and WistarKyoto rats. Life Sci 45:1089-1095, 1989
22. Bull BS, Chien S, Dormandy JA, et al: Guidelines for measurement of blood viscosity and erythrocyte deformability. Clin Hemorheol 6:439-453, 1986
23. Greenhouse SW, Geisser S: On methods in the analysis of profile data. Psychometrika 24:95-112, 1959
24. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:365-374, 1984
25. Beigel Y, Fuchs J, Snir M, et al: Lovastatin therapy in heterozygous familial hypercholesterolemic patients: Effect on blood rheology and fibrinogen levels. J Intern Med 230:23-27, 1991
26. Badimon JJ, Badimon L, Turitto VT, et al: Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels: In vivo study in the rabbit model. Arterioscler Thromb 11:395-402, 1991
27. Murakawa K, Kohno M, Takeda T: Effect of high-cholesterol diet on erythrocyte deformability in rats with a laser diffractometry. Jpn J Atheroscler Thromb 20:891-895, 1992
28. Shiga T, Maeda N, Suda T, et al: Rheological and kinetic dysfunctions of the cholesterol-loaded, human erythrocytes. Biorheology 16:363-369, 1979
29. Kanakaraj P, Singh M: Influence of hypercholesterolemia on morphological and rheological characteristics of erythrocytes. Atherosclerosis 76:209-218, 1989
30. Kanakaraj P, Singh M: Influence of cholesterol-enrichment under in vivo and in vitro conditions on the erythrocyte membrane lipids and its deformability. Indian J Biochem Biophys 26:381-385, 1989
31. Kazumichi K, Ohnishi S: Phosphatidylcholine transfer activity in human erythrocyte hemolysate. J Biochem 94:1809-1819, 1983
32. Cooper RA, Arher EC, Wiley JS, et al: Modification of red cell membrane structure by cholesterol rich lipid dispersions. J Clin Invest 55:115-126, 1975
33. Shepherd J. Gobbe SM, Ford I, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301-1307, 1995